跳至主要内容
临床试验/IRCT20190711044175N1
IRCT20190711044175N1招募中1 期

Cell therapy using human endometrial stem cell(hEnSCs) in patients with Secondary progressive-MS(SPMS): Phase I clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • (1)Women with SPMS who did not respond to their disease-modifying therapies .
  • (2) Age between 18–45 years
  • (3) EDSS less than 5.5
  • (4) Disease duration of 2 - 15 years..
  • (5) Women with at least one delivery
  • (6) Women who are taking Rituximab drugs

排除标准

  • Women under the age of 18 and over 45 years
  • Pregnant patients
  • Patients with positive results from screening tests for hepatitis B and C, human immunode?ciency virus (HIV), and human T-cell lymphotropic virus (HTLV) were also excluded from the study.
  • Patients who had used cytotoxic agents or hormonal therapy within 3 months prior to the study .
  • Patients with endometriosis and other uterine problems

研究者

相似试验